BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 27087131)

  • 1. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
    Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
    Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NFκB/c-Jun activation in breast cancer MDA-MB-231 cells.
    Chen YJ; Lee YC; Huang CH; Chang LS
    Toxicol Appl Pharmacol; 2016 Nov; 310():98-107. PubMed ID: 27634460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl.
    Chen YJ; Chang LS
    Mol Nutr Food Res; 2012 Sep; 56(9):1398-412. PubMed ID: 22865631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCalpha-dependent signaling pathways.
    Lee IT; Lin CC; Wu YC; Yang CM
    J Cell Physiol; 2010 Aug; 224(2):454-64. PubMed ID: 20333651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells.
    Chen YJ; Chang LS
    Biochim Biophys Acta; 2015 Oct; 1849(10):1248-59. PubMed ID: 26260845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of EGF-induced migration and invasion by sulfated polysaccharide of Sepiella maindroni ink via the suppression of EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells.
    Jiang W; Tian W; Ijaz M; Wang F
    Biomed Pharmacother; 2017 Nov; 95():95-102. PubMed ID: 28830011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
    Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
    Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin Enhanced Matrix Metalloproteinase-9 Expression and Migration of SK-N-SH Cells via PAR-1, c-Src, PYK2, EGFR, Erk1/2 and AP-1.
    Yang CC; Hsiao LD; Yang CM; Lin CC
    Mol Neurobiol; 2017 Jul; 54(5):3476-3491. PubMed ID: 27181591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Src-dependent transactivation of PDGFR contributes to TNF-α-induced MMP-9 expression and functional impairment in osteoblasts.
    Tsai CL; Chen WC; Lee IT; Chi PL; Cheng SE; Yang CM
    Bone; 2014 Mar; 60():186-97. PubMed ID: 24361597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells.
    Park SH; Kim JH; Lee DH; Kang JW; Song HH; Oh SR; Yoon DY
    Biochimie; 2013 Nov; 95(11):2082-90. PubMed ID: 23933110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
    Majumder A; Ray S; Banerji A
    Mol Cell Biochem; 2019 Feb; 452(1-2):111-121. PubMed ID: 30074136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Src-dependent MAPKs/AP-1 activation is involved in TNF-α-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells.
    Yang CM; Lee IT; Lin CC; Wang CH; Cherng WJ; Hsiao LD
    Biochem Pharmacol; 2013 Apr; 85(8):1115-23. PubMed ID: 23353699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
    Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
    Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
    Chen HJ; Lin CM; Lee CY; Shih NC; Amagaya S; Lin YC; Yang JS
    Int J Oncol; 2013 Aug; 43(2):629-37. PubMed ID: 23754208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.